05:12 PM EDT, 07/02/2025 (MT Newswires) -- Cellectis ( CLLS ) said late Wednesday that it plans to offer up to $200 million in securities, comprising ordinary shares, American depositary shares, preferred shares, and warrants, through one or more future offerings.

The securities may be sold via underwriters, agents, or directly to purchasers, the company said in a filing with the US Securities and Exchange Commission.

Net proceeds will likely be used for working capital and other general corporate purposes.